LifeMD, Inc. (LFMD) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-847.8%

-$17.27

vs $2.31 price

Levered DCF

-$9.26

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

-2.25

Distress zone

Rating

D+

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-14.83×	-9.34×	-11.84×	-1.24×	-1.7×	-1.54×	-1.67×	-5×
P/B	6.65×	-37.17×	80.18×	-8.8×	3.89×	68.85×	-6.01×	6.89×
P/S	0.79×	0.96×	1.84×	0.5×	1.13×	2.5×	0.48×	0.74×
EV / EBITDA	-81.36×	-29.16×	-32.49×	-1.68×	-1.13×	-1.48×	-2.22×	-3.36×
Gross margin	79.8%	88.7%	87.6%	84.3%	80.6%	76.2%	79.7%	76.3%
Operating margin	-4.0%	-7.6%	-9.5%	-36.5%	-58.5%	-155.0%	-23.2%	-24.7%
Net margin	-3.7%	-8.9%	-13.5%	-38.3%	-65.6%	-157.3%	-25.2%	-14.9%
Current ratio	1.25×	0.81×	1.22×	0.36×	1.97×	0.89×	0.69×	1.35×
Debt / equity	0.27×	-4.58×	5.4×	-0.6×	0.07×	0.79×	-0.85×	0.28×
Interest coverage	-5.64×	-7.4×	-5.58×	-34.05×	-17.98×	-34.67×	-3.8×	-5.8×
Dividend yield	2.0%	1.5%	1.1%	5.2%	0.8%	1.4%	0.0%	0.0%
Payout ratio	-43.7%	-16.5%	-15.1%	-6.8%	-1.4%	-2.2%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-30.7%	344.2%	-587.6%	666.7%	-226.8%	-4331.6%	317.5%	-138.2%
Return on invested capital	-26.0%	-76.3%	-58.8%	2016.2%	-195.5%	-16872.2%	-978.3%	-112.7%
Return on assets	-10.1%	-26.1%	-35.2%	-177.4%	-122.0%	-437.6%	-91.0%	-47.4%
Free cash flow yield	-0.8%	2.9%	0.0%	-59.6%	-34.9%	-13.4%	4.2%	-16.3%
Earnings yield	-4.6%	-9.3%	-7.3%	-75.8%	-58.3%	-62.9%	-52.8%	-20.1%
Enterprise value	$123.4M	$194M	$266.9M	$60.3M	$65M	$85.1M	$5.7M	$6.3M
Net debt / EBITDA	20.08×	1.49×	1.73×	-0×	0.69×	0.14×	0.1×	-0.04×
Cash conversion cycle (days)	-88	-186	-148	-117	-147	-367	-293	33